IDL Diagnostics taps Analyst Group for equity research coverage

• IDL Diagnostics entered a partnership with Analyst Group for equity research coverage.
• Coverage shifts from Redeye Nordic Growth, which previously provided research on the company.
• Analyst Group will begin coverage with IDL Diagnostics’ Q2 2026 interim report, due Aug. 20.
• Change applies only to research coverage; Redeye remains the company’s Certified Adviser.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDL Diagnostics AB (publ) published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.